227 related articles for article (PubMed ID: 8759741)
1. The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding.
Tamm A; Schmidt RE
J Immunol; 1996 Aug; 157(4):1576-81. PubMed ID: 8759741
[TBL] [Abstract][Full Text] [Related]
2. Membrane-proximal Ig-like domain of Fc gamma RIII (CD16) contains residues critical for ligand binding.
Hibbs ML; Tolvanen M; Carpén O
J Immunol; 1994 May; 152(9):4466-74. PubMed ID: 7512596
[TBL] [Abstract][Full Text] [Related]
3. Human Fc gamma RIII (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells.
Edberg JC; Redecha PB; Salmon JE; Kimberly RP
J Immunol; 1989 Sep; 143(5):1642-9. PubMed ID: 2474607
[TBL] [Abstract][Full Text] [Related]
4. Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors.
Ierino FL; Hulett MD; McKenzie IF; Hogarth PM
J Immunol; 1993 Mar; 150(5):1794-803. PubMed ID: 7679695
[TBL] [Abstract][Full Text] [Related]
5. The difference of binding epitopes on human CD16 (FcgammaRIII) interacted with hIgG1 and monoclonal antibody B88-9.
Feng J; Xie Z; Yu M; Guo N; Shen B
Mol Immunol; 2004 May; 41(1):93-8. PubMed ID: 15140580
[TBL] [Abstract][Full Text] [Related]
6. Evidence for cross-regulation of Fc gamma RIIIB (CD16) receptor-mediated signaling by Fc gamma RII (CD32) expressed on polymorphonuclear neutrophils.
Naziruddin B; Duffy BF; Tucker J; Mohanakumar T
J Immunol; 1992 Dec; 149(11):3702-9. PubMed ID: 1431142
[TBL] [Abstract][Full Text] [Related]
7. Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding.
Edberg JC; Kimberly RP
J Immunol; 1997 Oct; 159(8):3849-57. PubMed ID: 9378972
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function.
Guyre PM; Graziano RF; Vance BA; Morganelli PM; Fanger MW
J Immunol; 1989 Sep; 143(5):1650-5. PubMed ID: 2474608
[TBL] [Abstract][Full Text] [Related]
9. A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa.
de Haas M; Koene HR; Kleijer M; de Vries E; Simsek S; van Tol MJ; Roos D; von dem Borne AE
J Immunol; 1996 Apr; 156(8):2948-55. PubMed ID: 8609432
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Fc gamma and complement receptor function by the glycosyl-phosphatidylinositol-anchored form of Fc gamma RIII.
Edberg JC; Kimberly RP
J Immunol; 1994 Jun; 152(12):5826-35. PubMed ID: 8207210
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules.
Stöckl J; Majdic O; Pickl WF; Rosenkranz A; Prager E; Gschwantler E; Knapp W
J Immunol; 1995 May; 154(10):5452-63. PubMed ID: 7730647
[TBL] [Abstract][Full Text] [Related]
12. Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype.
Congy-Jolivet N; Bolzec A; Ternant D; Ohresser M; Watier H; Thibault G
Cancer Res; 2008 Feb; 68(4):976-80. PubMed ID: 18281470
[TBL] [Abstract][Full Text] [Related]
13. Soluble Fc gamma RIIIa is present in plasma and is derived from natural killer cells.
de Haas M; Kleijer M; Minchinton RM; Roos D; von dem Borne AE
J Immunol; 1994 Jan; 152(2):900-7. PubMed ID: 8283059
[TBL] [Abstract][Full Text] [Related]
14. Identification of residues in the first domain of human Fc alpha receptor essential for interaction with IgA.
Wines BD; Hulett MD; Jamieson GP; Trist HM; Spratt JM; Hogarth PM
J Immunol; 1999 Feb; 162(4):2146-53. PubMed ID: 9973489
[TBL] [Abstract][Full Text] [Related]
15. Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells.
Vance BA; Huizinga TW; Wardwell K; Guyre PM
J Immunol; 1993 Dec; 151(11):6429-39. PubMed ID: 8245476
[TBL] [Abstract][Full Text] [Related]
16. A new set of monoclonal antibodies against human Fc gamma RII (CD32) and Fc gamma RIII (CD16): characterization and use in various assays.
Vely F; Gruel N; Moncuit J; Cochet O; Rouard H; Dare S; Galon J; Sautes C; Fridman WH; Teillaud JL
Hybridoma; 1997 Dec; 16(6):519-28. PubMed ID: 9455704
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD16-2, a novel mouse receptor homologous to CD16/Fc gamma RIII.
Mechetina LV; Najakshin AM; Alabyev BY; Chikaev NA; Taranin AV
Immunogenetics; 2002 Oct; 54(7):463-8. PubMed ID: 12389094
[TBL] [Abstract][Full Text] [Related]
18. Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
Galatiuc C; Gherman M; Metes D; Sulica A; DeLeo A; Whiteside TL; Herberman RB
Cell Immunol; 1995 Jul; 163(2):167-77. PubMed ID: 7606790
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrates on human Fc gamma receptors. Interdependence of the classical IgG and nonclassical lectin-binding sites on human Fc gamma RIII expressed on neutrophils.
Kimberly RP; Tappe NJ; Merriam LT; Redecha PB; Edberg JC; Schwartzman S; Valinsky JE
J Immunol; 1989 Jun; 142(11):3923-30. PubMed ID: 2523939
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody.
Graziano RF; Tempest PR; White P; Keler T; Deo Y; Ghebremariam H; Coleman K; Pfefferkorn LC; Fanger MW; Guyre PM
J Immunol; 1995 Nov; 155(10):4996-5002. PubMed ID: 7594506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
